terminally ill patient (18-100 year) in emergency department who declined life -sustaining treatment (CPR, intubation, Inotrope, Hemodyalysis) present with dyspnea and RR more than24 Nebulized Fentanyl, Intravenous Fentanyl, Dyspnea, Terminally Ill
Conditions
Interventions
Fentanyl NB 25 mcg plus NSS up to 4 ml maximum 50 mcg per dose Maximum 300 mcg per day and NSS 3 ml IV,Fentanyl IV 25 mcg maximum 50 mcg per dose maximum 200 mcg IV per hour and NSS 4 ml NB
Experimental Drug,Active Comparator Drug
Fentanyl NB ,Fentanyl IV
Sponsors
FacultyofMedicine Ramathibodi Hospital, Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.terminally ill patient (18-100 year) in emergency department 2. who declined life -sustaining treatment (CPR, intubation, Inotrope, Hemodyalysis) 3. present with dyspnea and RR more than 24
Exclusion criteria
Exclusion criteria: 1. terminally ill patient who require life -sustaining treatment 2. allergy in fentanyl 3. obstruction of nasal passage, Nasopharyngeal cancer, Paranasal sinus malignancies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| respiratory rate 15, 30, 60 Minute per Minute | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory Distress Observation Scale 15, 30, 60 minute Respiratory Distress Observation Scale,oxygen saturation 15, 30, 60 minute percent,adverse effect oxygen saturation symptom | — |
Countries
Thailand
Contacts
Public ContactPitsucha Sanguanwit
Faculty of Medicine Ramathibodi Hospital
Outcome results
None listed